Cargando…
Time to TAVI: streamlining the pathway to treatment
INTRODUCTION: Severe aortic stenosis is a major cause of morbidity and mortality. The existing treatment pathway for transcatheter aortic valve implantation (TAVI) traditionally relies on tertiary Heart Valve Centre workup. However, this has been associated with delays to treatment, in breach of Bri...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481834/ https://www.ncbi.nlm.nih.gov/pubmed/37666643 http://dx.doi.org/10.1136/openhrt-2022-002170 |
_version_ | 1785102061323419648 |
---|---|
author | Hewitson, Lynsey Jane Cadiz, Suzane Al-Sayed, Sameeha Fellows, Sarah Amin, Alaaeldin Asimakopoulos, George Barnes, Edward Beale, Andrew Browne, Suzy Chandrasekaran, Badrinathan Dalby, Miles Foley, Paul Hawkins, Mark Haynes, Douglas Heng, Ee Ling Hyde, Tom Kabir, Tito Khavandi, Ali Mirsadraee, Saeed McCrea, William Petrou, Mario Senior, Roxy Smith, David Smith, Robert Spartera, Marco Wamil, Malgorzata Panoulas, Vasileios Rahbi, Hazim |
author_facet | Hewitson, Lynsey Jane Cadiz, Suzane Al-Sayed, Sameeha Fellows, Sarah Amin, Alaaeldin Asimakopoulos, George Barnes, Edward Beale, Andrew Browne, Suzy Chandrasekaran, Badrinathan Dalby, Miles Foley, Paul Hawkins, Mark Haynes, Douglas Heng, Ee Ling Hyde, Tom Kabir, Tito Khavandi, Ali Mirsadraee, Saeed McCrea, William Petrou, Mario Senior, Roxy Smith, David Smith, Robert Spartera, Marco Wamil, Malgorzata Panoulas, Vasileios Rahbi, Hazim |
author_sort | Hewitson, Lynsey Jane |
collection | PubMed |
description | INTRODUCTION: Severe aortic stenosis is a major cause of morbidity and mortality. The existing treatment pathway for transcatheter aortic valve implantation (TAVI) traditionally relies on tertiary Heart Valve Centre workup. However, this has been associated with delays to treatment, in breach of British Cardiovascular Intervention Society targets. A novel pathway with emphasis on comprehensive patient workup at a local centre, alongside close collaboration with a Heart Valve Centre, may help reduce the time to TAVI. METHODS: The centre performing local workup implemented a novel TAVI referral pathway. Data were collected retrospectively for all outpatients referred for consideration of TAVI to a Heart Valve Centre from November 2020 to November 2021. The main outcome of time to TAVI was calculated as the time from Heart Valve Centre referral to TAVI, or alternative intervention, expressed in days. For the centre performing local workup, referral was defined as the date of multidisciplinary team discussion. For this centre, a total pathway time from echocardiographic diagnosis to TAVI was also evaluated. A secondary outcome of the proportion of referrals proceeding to TAVI at the Heart Valve Centre was analysed. RESULTS: Mean±SD time from referral to TAVI was significantly lower at the centre performing local workup, when compared with centres with traditional referral pathways (32.4±64 to 126±257 days, p<0.00001). The total pathway time from echocardiographic diagnosis to TAVI for the centre performing local workup was 89.9±67.6 days, which was also significantly shorter than referral to TAVI time from all other centres (p<0.003). Centres without local workup had a significantly lower percentage of patients accepted for TAVI (49.5% vs 97.8%, p<0.00001). DISCUSSION: A novel TAVI pathway with emphasis on local workup within a non-surgical centre significantly reduced both the time to TAVI and rejection rates from a Heart Valve Centre. If adopted across the other centres, this approach may help improve access to TAVI. |
format | Online Article Text |
id | pubmed-10481834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-104818342023-09-07 Time to TAVI: streamlining the pathway to treatment Hewitson, Lynsey Jane Cadiz, Suzane Al-Sayed, Sameeha Fellows, Sarah Amin, Alaaeldin Asimakopoulos, George Barnes, Edward Beale, Andrew Browne, Suzy Chandrasekaran, Badrinathan Dalby, Miles Foley, Paul Hawkins, Mark Haynes, Douglas Heng, Ee Ling Hyde, Tom Kabir, Tito Khavandi, Ali Mirsadraee, Saeed McCrea, William Petrou, Mario Senior, Roxy Smith, David Smith, Robert Spartera, Marco Wamil, Malgorzata Panoulas, Vasileios Rahbi, Hazim Open Heart Valvular Heart Disease INTRODUCTION: Severe aortic stenosis is a major cause of morbidity and mortality. The existing treatment pathway for transcatheter aortic valve implantation (TAVI) traditionally relies on tertiary Heart Valve Centre workup. However, this has been associated with delays to treatment, in breach of British Cardiovascular Intervention Society targets. A novel pathway with emphasis on comprehensive patient workup at a local centre, alongside close collaboration with a Heart Valve Centre, may help reduce the time to TAVI. METHODS: The centre performing local workup implemented a novel TAVI referral pathway. Data were collected retrospectively for all outpatients referred for consideration of TAVI to a Heart Valve Centre from November 2020 to November 2021. The main outcome of time to TAVI was calculated as the time from Heart Valve Centre referral to TAVI, or alternative intervention, expressed in days. For the centre performing local workup, referral was defined as the date of multidisciplinary team discussion. For this centre, a total pathway time from echocardiographic diagnosis to TAVI was also evaluated. A secondary outcome of the proportion of referrals proceeding to TAVI at the Heart Valve Centre was analysed. RESULTS: Mean±SD time from referral to TAVI was significantly lower at the centre performing local workup, when compared with centres with traditional referral pathways (32.4±64 to 126±257 days, p<0.00001). The total pathway time from echocardiographic diagnosis to TAVI for the centre performing local workup was 89.9±67.6 days, which was also significantly shorter than referral to TAVI time from all other centres (p<0.003). Centres without local workup had a significantly lower percentage of patients accepted for TAVI (49.5% vs 97.8%, p<0.00001). DISCUSSION: A novel TAVI pathway with emphasis on local workup within a non-surgical centre significantly reduced both the time to TAVI and rejection rates from a Heart Valve Centre. If adopted across the other centres, this approach may help improve access to TAVI. BMJ Publishing Group 2023-09-04 /pmc/articles/PMC10481834/ /pubmed/37666643 http://dx.doi.org/10.1136/openhrt-2022-002170 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Valvular Heart Disease Hewitson, Lynsey Jane Cadiz, Suzane Al-Sayed, Sameeha Fellows, Sarah Amin, Alaaeldin Asimakopoulos, George Barnes, Edward Beale, Andrew Browne, Suzy Chandrasekaran, Badrinathan Dalby, Miles Foley, Paul Hawkins, Mark Haynes, Douglas Heng, Ee Ling Hyde, Tom Kabir, Tito Khavandi, Ali Mirsadraee, Saeed McCrea, William Petrou, Mario Senior, Roxy Smith, David Smith, Robert Spartera, Marco Wamil, Malgorzata Panoulas, Vasileios Rahbi, Hazim Time to TAVI: streamlining the pathway to treatment |
title | Time to TAVI: streamlining the pathway to treatment |
title_full | Time to TAVI: streamlining the pathway to treatment |
title_fullStr | Time to TAVI: streamlining the pathway to treatment |
title_full_unstemmed | Time to TAVI: streamlining the pathway to treatment |
title_short | Time to TAVI: streamlining the pathway to treatment |
title_sort | time to tavi: streamlining the pathway to treatment |
topic | Valvular Heart Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481834/ https://www.ncbi.nlm.nih.gov/pubmed/37666643 http://dx.doi.org/10.1136/openhrt-2022-002170 |
work_keys_str_mv | AT hewitsonlynseyjane timetotavistreamliningthepathwaytotreatment AT cadizsuzane timetotavistreamliningthepathwaytotreatment AT alsayedsameeha timetotavistreamliningthepathwaytotreatment AT fellowssarah timetotavistreamliningthepathwaytotreatment AT aminalaaeldin timetotavistreamliningthepathwaytotreatment AT asimakopoulosgeorge timetotavistreamliningthepathwaytotreatment AT barnesedward timetotavistreamliningthepathwaytotreatment AT bealeandrew timetotavistreamliningthepathwaytotreatment AT brownesuzy timetotavistreamliningthepathwaytotreatment AT chandrasekaranbadrinathan timetotavistreamliningthepathwaytotreatment AT dalbymiles timetotavistreamliningthepathwaytotreatment AT foleypaul timetotavistreamliningthepathwaytotreatment AT hawkinsmark timetotavistreamliningthepathwaytotreatment AT haynesdouglas timetotavistreamliningthepathwaytotreatment AT hengeeling timetotavistreamliningthepathwaytotreatment AT hydetom timetotavistreamliningthepathwaytotreatment AT kabirtito timetotavistreamliningthepathwaytotreatment AT khavandiali timetotavistreamliningthepathwaytotreatment AT mirsadraeesaeed timetotavistreamliningthepathwaytotreatment AT mccreawilliam timetotavistreamliningthepathwaytotreatment AT petroumario timetotavistreamliningthepathwaytotreatment AT seniorroxy timetotavistreamliningthepathwaytotreatment AT smithdavid timetotavistreamliningthepathwaytotreatment AT smithrobert timetotavistreamliningthepathwaytotreatment AT sparteramarco timetotavistreamliningthepathwaytotreatment AT wamilmalgorzata timetotavistreamliningthepathwaytotreatment AT panoulasvasileios timetotavistreamliningthepathwaytotreatment AT rahbihazim timetotavistreamliningthepathwaytotreatment |